Clinical Trials Browser

Phase 1/2 × Active not recruiting × Hydrocortisone × Clear all

NCT03817320 2025-06-17

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Phase 1/2 Active not recruiting

24 enrolled 11 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma